These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 18454233)
1. Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols. Khattab TM; Atra AA; Elimam NA; Kassar A; Zayed A; Baothman A Saudi Med J; 2008 May; 29(5):776-7. PubMed ID: 18454233 [No Abstract] [Full Text] [Related]
2. A homoharringtonine-based regimen for childhood acute myelogenous leukemia. Tang J; Xue H; Pan C; Chen J; Gu L; Zhao H Med Pediatr Oncol; 2003 Jul; 41(1):70-2. PubMed ID: 12764750 [No Abstract] [Full Text] [Related]
3. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience. Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308 [No Abstract] [Full Text] [Related]
4. Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study. Taga T; Shimomura Y; Horikoshi Y; Ogawa A; Itoh M; Okada M; Ueyama J; Higa T; Watanabe A; Kanegane H; Iwai A; Saiwakawa Y; Kogawa K; Yamanaka J; Tsurusawa M Pediatr Blood Cancer; 2011 Jul; 57(1):36-40. PubMed ID: 21557456 [TBL] [Abstract][Full Text] [Related]
5. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide]. Robak T; Krykowski E; Matusewicz W; Brodowski L; Hołub A; Drzewoski J Pol Tyg Lek; 1988 Nov; 43(47):1508-11. PubMed ID: 3075284 [No Abstract] [Full Text] [Related]
6. What's up with down syndrome and leukemia-A lot! Taub JW; Ravindranath Y Pediatr Blood Cancer; 2011 Jul; 57(1):1-3. PubMed ID: 21480471 [No Abstract] [Full Text] [Related]
7. Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia. Salvucci M; Zanchini R; Molinari A; Zuffa E; Poletti V; Poletti G; Zaccaria A Haematologica; 2000 Jul; 85(7):769-70. PubMed ID: 10897135 [No Abstract] [Full Text] [Related]
8. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group. Kudo K; Kojima S; Tabuchi K; Yabe H; Tawa A; Imaizumi M; Hanada R; Hamamoto K; Kobayashi R; Morimoto A; Nakayama H; Tsuchida M; Horibe K; Kigasawa H; Tsukimoto I; J Clin Oncol; 2007 Dec; 25(34):5442-7. PubMed ID: 18048827 [TBL] [Abstract][Full Text] [Related]
9. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502 [TBL] [Abstract][Full Text] [Related]
10. Relapse and death during first remission in acute myeloid leukemia. Yanada M; Garcia-Manero G; Borthakur G; Ravandi F; Kantarjian H; Estey E Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012 [No Abstract] [Full Text] [Related]
11. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia. Montillo M; Ricci F; Tedeschi A; Cafro AM; Nosari AM; Nichelatti M; Marbello L; Morra E Leuk Res; 2009 Aug; 33(8):1072-8. PubMed ID: 19187960 [TBL] [Abstract][Full Text] [Related]
12. [Possibilities for the cure of acute myeloblastic leukemia with the modified VAPA regimen: preliminary results]. Díaz Mediavilla J; del Potro Gómez E; Llorente Pérez L; Martínez Martínez R; Guerra Moyano JL; de la Vega Bueno E; Alvarez Carmona A; Krsnik Castelló I; Alarcón Zurita C; Rodríguez Vázquez M Med Clin (Barc); 1984 Dec; 83(19):783-6. PubMed ID: 6597329 [No Abstract] [Full Text] [Related]
13. Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia. Lee SS; Lee JH; Lee JH; Kim DY; Kim SH; Lim SN; Lee YS; Seol M; Ryu SG; Kang YA; Jang S; Park CJ; Chi HS; Yun SC; Lee KH Leuk Res; 2009 Apr; 33(4):511-7. PubMed ID: 18819710 [TBL] [Abstract][Full Text] [Related]
14. Family History and Relapse in Pediatric Acute Myeloid Leukemia. Mehrvar A; Tashvighi M; Faranoush M; Reinhardt D; Niktoreh Mofrad N; Hedayati Asl AA; Alebouyeh M Pediatr Blood Cancer; 2015 Dec; 62(12):2235-7. PubMed ID: 26184891 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia. Styczynski J; Wysocki M; Dluzniewska A; Juraszewska E; Balwierz W; Czyzewski K; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Stanczak E; Malinowska I; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Kapuscinska L; Szczepanek J; Kolodziej B; Rafinska B; Kubicka M Anticancer Res; 2008; 28(3B):1927-31. PubMed ID: 18630483 [TBL] [Abstract][Full Text] [Related]
16. Long term results in acute non-lymphocytic leukaemia. Saikia TK; Rajni A; Gopal R; Nair CN; Nadkarni KS; Kurkure PA; Pai VR; Pai SK; Advani SH J Assoc Physicians India; 1988 Aug; 36(8):505-7. PubMed ID: 3073153 [No Abstract] [Full Text] [Related]